Notable Labs (VBLT) Stock Forecast, Price Target & Predictions
VBLT Stock Forecast
Notable Labs stock forecast is as follows: an average price target of $5.00 (represents a 3125.81% upside from VBLT’s last price of $0.15) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
VBLT Price Target
The average price target for Notable Labs (VBLT) is $5.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $5.00 to $5.00. This represents a potential 3125.81% upside from VBLT's last price of $0.15.
VBLT Analyst Ratings
According to 2 Wall Street analysts, Notable Labs's rating consensus is 'Buy'. The analyst rating breakdown for VBLT stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Notable Labs Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Apr 28, 2022 | - | Chardan Capital | $5.00 | $1.57 | 218.47% | 3125.81% |
The latest Notable Labs stock forecast, released on Apr 28, 2022 by Chardan Capital company, set a price target of $5.00, which represents a 218.47% increase from the stock price at the time of the forecast ($1.57), and a 3125.81% increase from VBLT last price ($0.15).
Notable Labs Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $0.15 | $0.15 | $0.15 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Notable Labs stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Notable Labs's last price of $0.15. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jul 20, 2022 | Morgan Stanley | - | Overweight | Upgrade |
| Apr 28, 2022 | Chardan Capital | - | Buy | Initialise |
Notable Labs's last stock rating was published by Morgan Stanley on Jul 20, 2022. The company Upgrade its VBLT rating from "null" to "Overweight".
Notable Labs Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| VBLT | Notable Labs | $0.16 | $5.00 | 3025.00% | Buy |
| XFOR | X4 Pharmaceuticals | $0.34 | $3.67 | 979.41% | Buy |
| ATXI | Avenue Therapeutics | $2.01 | $12.00 | 497.01% | Buy |
| INZY | Inozyme Pharma | $2.79 | $14.67 | 425.81% | Buy |
| ZURA | Zura Bio | $2.90 | $10.00 | 244.83% | Buy |
| ABOS | Acumen Pharmaceuticals | $2.37 | $7.00 | 195.36% | Buy |
| DAWN | Day One Biopharmaceuticals | $13.62 | $38.80 | 184.88% | Buy |
| TERN | Terns Pharmaceuticals | $5.60 | $14.25 | 154.46% | Buy |
| HOOK | HOOKIPA Pharma | $2.72 | $3.00 | 10.29% | Buy |